All for giving Arcam credit for EBM equipment (and obtaining patents to protect their IP) but it really looks like the bulk of the experimentation and qualification of new metals is being done by universities, publicly funded institutions, and many of their commercial and industrial customers.
Arcam management will have more than enough work to do growing the business. They seem to be firing on all cylinders.
Industrifonden, Arcam's largest shareholder, has a vision statment that says "We want to be an innovative investor that creates lasting value."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.